Champions Oncology Inc (CSBR)

NASDAQ
Currency in USD
11.070
+0.010(+0.09%)
Closed
After Hours
11.0700.000(0.00%)
CSBR Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
10.73711.330
52 wk Range
3.60011.990
Key Statistics
Edit
Prev. Close
11.06
Open
11.04
Day's Range
10.737-11.33
52 wk Range
3.6-11.99
Volume
31.19K
Average Volume (3m)
56.96K
1-Year Change
95.24%
Book Value / Share
0.05
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CSBR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
8.000
Downside
-27.73%
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets
Show more

Champions Oncology Inc Company Profile

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Champions Oncology Inc Earnings Call Summary for Q2/2025

  • Champions Oncology reports Q2 2024 EPS of $0.05, beating -$0.03 forecast; revenue reaches $13.5M, up 17% YoY
  • Stock surges 10.15% after-hours on positive earnings surprise; company achieves GAAP income from operations of $700,000
  • Gross margin improves to 45%; adjusted EBITDA turns positive at $1.1M, reversing previous year's $1.4M loss
  • Company forecasts 10-15% revenue growth for FY2025; plans to launch data licensing revenue stream
  • CEO highlights transformative potential of data business; CFO expresses confidence in strong future financial results
Last Updated: 2024-12-11, 05:56 p/m
Read Full Transcript

Compare CSBR to Peers and Sector

Metrics to compare
CSBR
Peers
Sector
Relationship
P/E Ratio
−253.6x−8.3x−0.7x
PEG Ratio
−2.700.060.00
Price/Book
222.7x2.0x2.6x
Price / LTM Sales
2.8x3.0x3.1x
Upside (Analyst Target)
−27.7%41.4%45.9%
Fair Value Upside
Unlock12.1%8.3%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.000
(-27.73% Downside)

Earnings

Latest Release
Dec 11, 2024
EPS / Forecast
0.05 / -0.03
Revenue / Forecast
13.50M / 13.32M
EPS Revisions
Last 90 days

People Also Watch

8.630
ISSC
-18.51%
3.380
CMPX
-2.03%
12.78
ARQT
+3.82%
3.4800
RPID
-2.52%

FAQ

What Is the Champions Oncology (CSBR) Stock Price Today?

The Champions Oncology stock price today is 11.07

What Stock Exchange Does Champions Oncology Trade On?

Champions Oncology is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Champions Oncology?

The stock symbol for Champions Oncology is "CSBR."

What Is the Champions Oncology Market Cap?

As of today, Champions Oncology market cap is 151.65M.

What is Champions Oncology Earnings Per Share?

The Champions Oncology EPS is -0.044.

What Is the Next Champions Oncology Earnings Date?

Champions Oncology will release its next earnings report on Mar 18, 2025.

From a Technical Analysis Perspective, Is CSBR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.